TP53-mutated endometrial cancers and associations with race and survival outcomes

被引：0

作者：

Whelan, Karley ^{[1
]}

Thomas, Samantha ^{[2
,3
]}

Pothuri, Bhavana ^{[4
]}

Bae-Jump, Victoria ^{[5
]}

Borden, Lindsay ^{[6
]}

Thaker, Premal ^{[7
]}

Haight, Paulina ^{[8
]}

Arend, Rebecca ^{[9
]}

Ko, Emily ^{[10
]}

Jackson, Amanda ^{[11
]}

Corr, Bradley ^{[12
]}

Konecny, Gottfried ^{[13
]}

Wright, Jason ^{[14
]}

Duska, Linda ^{[15
]}

Dillon, Mairead ^{[16
]}

Lightfoot, Michelle ^{[17
]}

Newton, Meredith ^{[5
]}

Washington, Christina ^{[18
]}

Mullen, Margaret ^{[7
]}

Cosgrove, Casey ^{[19
]}

Horsono, Adrian

Powell, Kristina

Herzog, Thomas ^{[20
]}

Salani, Ritu ^{[21
]}

Secord, Angeles Alvarez ^{[22
]}

机构：

[1] Duke Univ, Sch Med, Durham, NC USA

[2] Duke Canc Inst, Durham, NC USA

[3] Duke Dept Biostat & Bioinformat, Durham, NC USA

[4] Duke Univ, NYU Langone Hlth, Durham, NC USA

[5] Univ N Carolina, Chapel Hill, NC USA

[6] Univ Oklahoma, Norman, OK USA

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA

[9] Univ Alabama Birmingham, Birmingham, AL USA

[10] Univ Penn, Philadelphia, PA USA

[11] Univ Cincinnati, Cincinnati, OH USA

[12] Univ Colorado, Canc Ctr, Boulder, CO USA

[13] Univ Calif Los Angeles, Los Angeles, CA USA

[14] Columbia Univ, New York, NY USA

[15] Univ Virginia, Charlottesville, VA USA

[16] Duke Univ, Durham, NC USA

[17] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[18] Univ Oklahoma, Hlth Sci Ctr, Norman, OK USA

[19] Ohio State Univ, Columbus, OH USA

[20] Univ Cincinnati, Inst Canc, Cincinnati, OH USA

[21] Univ Calif Los Angeles, Los Angeles, CA USA

[22] Duke Univ, Med Ctr, Durham, NC USA

来源：

GYNECOLOGIC ONCOLOGY | 2023年 / 173卷

关键词：

D O I：

10.1016/j.ygyno.2023.05.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S2 / S3

页数：2

共 50 条

[1] Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas
Momeni-Boroujeni, Amir
Dahoud, Wissam
Vanderbilt, Chad M.
Chiang, Sarah
Murali, Rajmohan
Rios-Doria, Eric, V
Alektiar, Kaled M.
Aghajanian, Carol
Abu-Rustum, Nadeem R.
Ladanyi, Marc
Ellenson, Lora H.
Weigelt, Britta
Soslow, Robert A.
CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2613 - 2623
[2] Overall survival in TP53-mutated AML and MDS
Puzo, Christian J.
Hager, Karl M.
Rinder, Henry M.
Weinberg, Olga K.
Siddon, Alexa J.
ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5359 - 5369
[3] Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
Lee, Sunyoung S.
Cao, Hop Sanderson Tran
Tzeng, Ching-Wei David
Metwalli, Zeyad
Koay, Eugene Jon
Ludmir, Ethan B.
Chun, Yun Shin
Chun, Stephen G.
Javle, Milind M.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[4] Decitabine in TP53-Mutated AML
Montalban-Bravo, Guillermo
Takahashi, Koichi
Garcia-Manero, Guillermo
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 796 - 797
[5] Patterns of recurrence in surgically treated women for TP53-mutated endometrial carcinomas
Pain, Flore-Anne
Beinse, Guillaume
Azais, Henri
Auvray-Kuentz, Marie
Garcin, Louis-Marie
Delanoy, Nicolas
Bentivegna, Enrica
Benoit, Louise
Nguyen-Xuan, Huyen-Thu
Blons, Helene
Fabiano, Emmanuelle
Belda, Marie-Aude L. E. Frere
Bats, Anne-Sophie
Koual, Meriem
EJSO, 2023, 49 (09):
[6] Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
Zhang, Lijuan
Chen, Kankan
Li, Yingying
Chen, Qiuni
Shi, Wenting
Ji, Tingting
Tao, Hong
He, Zhengmei
Wang, Chunling
Yu, Liang
HEMATOLOGY, 2023, 28 (01)
[7] Outcomes with lower intensity therapy in TP53-mutated AML.
Kadia, Tapan M.
Boddu, Prajwal C.
Ravandi, Farhad
Garcia-Manero, Guillermo
Borthakur, Gautam
Andreeff, Michael
Jabbour, Elias
Dinardo, Courtney Denton
Konopleva, Marina
Daver, Naval Guastad
Takahashi, Koichi
Patel, Keyur
Kanagal-Shamanna, Rashmi
Cortes, Jorge E.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8] Decitabine in TP53-Mutated AML Reply
Welch, John S.
Petti, Allegra A.
Ley, Timothy J.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 797 - 798
[9] Treatment patterns and outcomes of patients with TP53-mutated chronic lymphocytic leukemia
Hwang, Steven
Wang, Yucai
Rabe, Kari
Williams-Watley, Marquise
Kenderian, Saad
Muchtar, Eli
Hampel, Paul
Kay, Neil
Koehler, Amber
Behnken, Amy
Leis, Jose
Braggio, Esteban
Shi, Min
Viswanatha, David
Van Dyke, Daniel
Slager, Susan
Parikh, Sameer
He, Rong
Ding, Wei
LEUKEMIA & LYMPHOMA, 2023, 64 : S84 - S85
[10] Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
Boddu, Prajwal
Kantarjian, Hagop
Ravandi, Farhad
Garcia-Manero, Guillermo
Borthakur, Gautam
Andreeff, Michael
Jabbour, Elias J.
Benton, Christopher B.
DiNardo, Courtney D.
Konopleva, Marina
Daver, Naval
Patel, Keyur
Takahashi, Koichi
Kanagal-Shamanna, Rashmi
Cortes, Jorge
Kadia, Tapan
LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2238 - 2241

← 1 2 3 4 5 →